Description: This report summarizes a study that estimates the total economic burden of the opioid crisis in the United States from 2015 through 2018 and projects future costs of the opioid epidemic for 2019.

Description: The level-funding approach to medical stop-loss insurance is growing in popularity, yet is highly specialized. This session will give the actuarial community an overview of level-funding, including the basic mechanics, the benefits of offering level-funding to clients, and the five keys to success, including the ability to underwrite this specialized coverage.

Description: This paper helps the audience understand the actuary’s role in estimating the financial impact of primary care programs. In addition, the paper can be used by actuaries to think about key issues when estimating the financial impact of their employers’ and clients’ own primary care programs.

Description: This is a brief report that summarizes recent changes in the prevalent medical loss ratio methodologies and also looks at some of the more recent experience of health insurers that filed medical loss ratio reports.

Description: This article details the medical stop-loss coverages purchased by HMOs, small insurers and providers taking delegated financial risk in payor agreements. Along the way we will identify strategies purchasers often use to save money on medical stop-loss.

Description: The actuarial profession and our stakeholders in the insurance industry are in a unique position to help quantify and mitigate environmental risks via pricing and benefit incentives. Property insurance prices and benefits can encourage responsible and sustainable development. By developing insurance markets and making various types of insurance available in developing regions, which are disproportionately affected by environmental risks and hazards, we can provide protection that is critical for economic development. In spite of the risks posed by environmental issues to actuaries and our stakeholders, and in spite of the opportunities for actuaries and our stakeholders to address environmental risks, actuarial literature is limited with respect to such topics as: environmental risks, including natural disasters, pollution, clean air and water, degradation of the natural and human environment, resource depletion and sustainability, climate change and its consequences; local, national, regional and global efforts to address environmental risks; methods and models used by the scientific community to study environmental risks; methods and assumptions used to quantify the economic or financial risk associated with environmental hazards. This webcast will feature three of the papers addressing these topics that have been published so far in this series of twelve papers. The authors of the papers will present their topics and attendees will be able to participate with questions and answers.

Description: The Society of Actuaries’ Committee on Finance Research and Investment Section are pleased to make available a research report explores gross domestic product (GDP) as a metric of economic growth.

Description: This research report educates the actuarial community about the various shades of the flood risk as well as the state of the art in quantitative flood risk modeling.

Description: The SOA, with SCOR as the researcher, completed an experience study of post-level term (PLT) lapse and mortality. In the first part of this session, the presenters will cover the key findings of the traditional analysis regarding the shock lapse, the PLT lapse and mortality experience. The remainder of the session will focus on the results of the predictive modeling, which will provide further insights into policyholder behavior in the post-level term period.

Description: Prior to the global pandemic, investment in new health technologies had already reached an all-time high. As the world begins to emerge from COVID-19, what new technologies will next take root in the health care system and how will those affect medical costs? This session will review recent research from the SOA Health Section on how new technologies are spread and adopted. Particular focus will be given to emerging modes of consumer engagement and highly-focused gene and cell therapies that are breaking new ground in combating rare diseases. (We plan on focusing on 2 technologies like Consumerism or Telehealth & Gene & Cell Therapy depending on availability of speakers or if there are other sessions in this virtual meeting covering the same topic)